Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

[News]

In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

More... (https://www.news-medical.net/news/20220830/Leukemia-drug-successfully-disrupts-HER2-positive-brain-metastasis-in-animal-studies.aspx)